Kalaris Therapeutics, Inc. (KLRS)

NASDAQ: KLRS · Real-Time Price · USD

2.900

-0.060 (-2.03%)

At close: May 30, 2025, 4:00 PM

3.040

+0.140 (4.83%)

After-hours: May 30, 2025, 4:02 PM EDT

Kalaris Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	May '25 May 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	-	-0.39	-	-0.61
Quick Ratio	14.14	0.07	0.80	0.54
Current Ratio	14.31	0.11	0.85	0.69
Return on Assets (ROA)	-	-681.04%	-232.72%	-
Buyback Yield / Dilution	-64.52%	-9.18%	-36.56%	-

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.